Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks

IF 3.4 3区生物学 Q3 CELL BIOLOGY

Cell Cycle Pub Date : 2024-04-19 DOI:10.1080/15384101.2024.2340859

Jiajun Xu, Raghad Abdulsalam Khaleel, Haider Kamil Zaidan, Ahmed Faisal Mutee, Khaled Fahmi Fawy, Anita Gehlot, Alaa Hashim Abbas, José Luis Arias Gonzáles, Ali H Amin, Maribel Carmen Ruiz-Balvin, Shima Imannezhad, Abolfazl Bahrami, Reza Akhavan-Sigari

引用次数: 0

Abstract

Angiotensin-converting enzyme 2 (ACE2) is identified as the functional receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the ongoing global coronavir...

查看原文本刊更多论文

发现COVID-19/哮喘合并症的共同分子特征和药物再利用：ACE2 和多方网络

血管紧张素转换酶 2 (ACE2) 被确定为严重急性呼吸系统综合征冠状病毒 2 (SARS-CoV-2) 的功能受体，而 SARS-CoV-2 是目前全球冠状病毒疫情的病原体。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cell Cycle 生物-细胞生物学

CiteScore

7.70

自引率

2.30%

发文量

281

审稿时长

1 months

期刊介绍： Cell Cycle is a bi-weekly peer-reviewed journal of high priority research from all areas of cell biology. Cell Cycle covers all topics from yeast to man, from DNA to function, from development to aging, from stem cells to cell senescence, from metabolism to cell death, from cancer to neurobiology, from molecular biology to therapeutics. Our goal is fast publication of outstanding research.